He Had the Worst Bloody Nose of His Life. That Was Just the Beginning.

The man’s unchecked bleeding was a mystery for years before a scan revealed the cause.
Medindia

Lilly's Jaypirca (pirtobrutinib) met its primary endpoint in first-of-its-kind, head-to-head Phase 3 study versus Imbruvica (ibrutinib)

In addition to meeting the primary endpoint of non-inferiority for overall response rate (ORR) in the BRUIN CLL-314 study, pirtobrutinib achieved a numerically higher ORR of 87.0% compared to 78.5% ...

Lilly's Jaypirca (pirtobrutinib) significantly improved progression-free survival, reducing the risk of progression or death by 80%, versus chemoimmunotherapy in …

Eli Lilly and Company (NYSE: LLY) today announced results from the Phase 3 BRUIN CLL-313 clinical trial of Jaypirca ...
Health.com

How To Identify a Lupus Butterfly Rash

David Ozeri, MD, FACP, FACR, is a rheumatologist and current researcher at Sheba Medical Center in Israel. He worked at Kings County Hospital Center and treated veterans at New York Harbor Healthcare ...